Results 71 to 80 of about 354 (138)

Complete plastome of Coelastrum microporum Nägeli (Scenedesmaceae, Sphaeropleales). [PDF]

Mitochondrial DNA B Resour, 2023
Lee C, Cooper JT, Moroni F, Salim AM, Lee C, Spanbauer T, Theriot EC.   +6 more
europepmc   +1 more source

Ablation of prostaglandin E₂ signalling through dual receptor knockout in CAR T cells enhances therapeutic efficacy in solid tumours. [PDF]

Nat Biomed Eng
Dörr J, Gregor L, Lacher SB, Oner A, Sun Y, Piseddu I, Fertig L, Spajic S, Lesch S, Michaelides S, Seifert M, Gottschlich A, Samson N, Majed L, Briukhovetska D, Simnica D, Hartmann V, Gabriel K, Cohen S, Boland GM, Andreu-Sanz D, Carlini E, Stock S, Holtermann A, Müller PJ, Strzalkowski T, Trefny MP, Endres S, Jenkins RW, Böttcher JP, Kobold S.   +30 more
europepmc   +1 more source

Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract Cancer. [PDF]

Clin Cancer Res
Cowzer D, Walch H, Atri P, Shah F, Huq R, Thummalapalli R, Nagib F, Varghese A, Khalil DN, Park W, Rousseau B, Cercek A, Erinjeri J, Yeh R, Do RK, Basturk O, Shia J, Chakravarty D, Berger MF, Schultz N, Gonen M, O'Reilly EM, Jarnagin W, Abou-Alfa GK, Solit DB, Chatila WK, Harding JJ.   +26 more
europepmc   +1 more source

Immunologic determinants of infusion products and the tumor microenvironment govern response to TIL therapy in advanced melanoma. [PDF]

Med
Karapetyan L, Xu J, Ward K, Kalos D, Schachner B, Ali J, Song X, Kuriakose J, Hall MS, Chau J, Cox CA, Al-Bzour AN, Falahat R, Perez MC, Mullinax JE, Zager JS, Gonzalez R, Sondak VK, Tsai KY, Messina JL, Moran-Segura C, Lopez-Blanco N, Alleyne AE, Nguyen JV, Schell MJ, Markowitz J, Brohl AS, Eroglu Z, Tarhini AA, Khushalani NI, Hwu P, Mulé JJ, Sarnaik AA, Beatty MS, Pilon-Thomas S.   +34 more
europepmc   +1 more source

Genetic Factors Associated with Clinical Response in Melanoma Patients Treated with Talimogene Laherparapvec: A Single-Institution Retrospective Analysis. [PDF]

Ann Surg Oncol
Sierra-Davidson K, Dedeilia A, Lawless A, Sharova T, Kaufman HL, Boland GM, Cohen S.   +6 more
europepmc   +1 more source

Preclinical Evaluation of an Anchored Immunotherapy Strategy with Aluminum Hydroxide-Tethered IL-12 in Dogs with Advanced Malignant Melanoma. [PDF]

Mol Cancer Ther
Passos Barbosa MM, Kamerer RL, Schmit J, Lopez AJ, Uyehara R, Tighe R, Battula S, Kaufman HL, Fan TM.   +8 more
europepmc   +1 more source

Loss of tumor-infiltrating lymphocytes and poor response to immunotherapy in IDH GOF mutant melanoma. [PDF]

JCI Insight
Specht E, Pakanati L, Wu MJ, Jenkins RW, Effiom DN, Bardeesy N, Bernstein BE, Sade-Feldman M, Lian CG, Boland GM, Torlai Triglia E, Cohen S.   +11 more
europepmc   +1 more source

Intratumorally anchored cytokine therapy. [PDF]

Expert Opin Drug Deliv, 2022
Wittrup KD, Kaufman HL, Schmidt MM, Irvine DJ.   +3 more
europepmc   +1 more source

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial. [PDF]

J Clin Oncol
Srour SA, Chahoud J, Drakaki A, Curti BD, Gibney GT, Tang L, Jiang Y, Charmsaz S, Robbins PB, McLeroy J, Severyn CJ, Le Gall JB, Roberts ZJ, Tannir NM, Pal S, Kotecha RR.   +15 more
europepmc   +1 more source

IL10R Inhibition Induces Neutrophil Tumoricidal Activity. [PDF]

Cancer Immunol Res
Khalil DN, Gomez R, Regev A, Samaan F, Marouf Y, Budhu S, Hirschhorn D, Schulze I, Lavery JA, Ceglia N, Freeman SS, Maltez VI, Garcia JM, Suek N, Weng CH, Cabanski CR, Monette S, Romin Y, Li Y, Chaligne R, Yellin MJ, Keler T, Maurer DM, Flamar AL, Morgado-Palacin L, Mangarin LM, Harding JJ, Park W, Lyman JP, Maddock S, O'Hara MH, Abou-Alfa GK, Vonderheide RH, O'Reilly EM, Germain RN, Wolchok JD, Merghoub T.   +36 more
europepmc   +1 more source